Aesthetic surgery journal
-
Aesthetic surgery journal · Mar 2010
Separating the helix from the antihelix: a new concept in prominent ear correction.
For over a century, various otoplasty techniques for correction of the prominent ear have been attempted. Nevertheless, cartilage memory strength, mainly in the thick cartilage (and consequently the recurrence of the prominence), still remains a problem. An additional difficulty relates to the antihelix irregularities caused by attempts to weaken the cartilage spring, which are time-consuming and in some cases lead to an unnatural-looking result. ⋯ The present technique introduces a new concept in otoplasty that avoids handling the antihelix cartilage. A single incision of the antihelix breaks the cartilage spring memory completely and allows rebuilding of the antihelical fold without resorting to techniques such as rasping, drilling, excision, or complete incision, all of which are time-consuming and may result in irregularities. Sutures are placed to create the new antihelix in the desired shape easily and without tension. The helix and earlobe are repositioned with a specific posterior skin resection and with the tail of the helix's replacement.
-
Aesthetic surgery journal · Nov 2009
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
A new formulation of a botulinum neurotoxin type A (BoNTA-ABO; Dysport [abobotulinumtoxinA]; Medicis Aesthetics, Scottsdale, AZ) was recently approved by the US Food and Drug Administration for the treatment of moderate to severe glabellar lines. ⋯ Treatment of glabellar lines with BoNTA-ABO is well tolerated. Overall, the safety profile of BoNTA-ABO is comparable to that of placebo in terms of type, frequency, severity, and relatedness of AE.
-
Aesthetic surgery journal · Sep 2009
Prevention of venous thromboembolism in the plastic surgery patient: current guidelines and recommendations.
Over the last five years, there has been a groundswell of interest in the prevention of venous thromboembolism (VTE). An increased level of understanding of the disease process coupled with data documenting the alarmingly high incidence of VTE has prompted a global awareness of the disease. Consequently, prevention of VTE has been targeted by hospitals, both in the United States and abroad, as a top priority to improve patient care. ⋯ As a result, VTE often goes undetected and, if allowed, can progress to PE. This typically delays treatment and results in high rates of morbidity and mortality. The combination of VTE being both difficult to detect and deadly if untreated makes it a disease that is best addressed with preventive rather than therapeutic measures.